Steward Partners Investment Advisory, LLC Ngm Biopharmaceuticals Inc Transaction History

Steward Partners Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $11,753 - $21,821	-4,817 Reduced 53.74%	4,146 $10,000
Q4 2022 Feb 15, 2023	BUY	$3.41 - $12.93 $3,242 - $12,296	951 Added 11.87%	8,963 $44,000
Q3 2022 Nov 10, 2022	BUY	$12.59 - $17.67 $40,225 - $56,455	3,195 Added 66.33%	8,012 $105,000
Q2 2022 Aug 04, 2022	BUY	$10.58 - $17.5 $29,624 - $49,000	2,800 Added 138.82%	4,817 $62,000
Q1 2022 May 02, 2022	BUY	$13.81 - $18.6 $27,854 - $37,516	2,017 New	2,017 $31,000
Q4 2021 Feb 08, 2022	SELL	$17.26 - $22.02 $34,520 - $44,040	-2,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$24.99 - $31.93 $49,980 - $63,860	2,000 New	2,000 $58,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.